SCHEMBL257428

SCHEMBL257428

CC1=CNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10013883 0.82
SCHEMBL10296592 0.80
SCHEMBL10296543 0.67
SCHEMBL10050844 0.63
SCHEMBL9912449 0.63
SCHEMBL30037332 0.62
SCHEMBL15942707 0.60
SCHEMBL171791 0.59
SCHEMBL10523922 0.57
SCHEMBL15680101 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110627809-A Polysubstituted thieno [2,3-b ] pyridine derivative and preparation method and application thereof 北京大学 2019-12-31 CN claimed
CN-122079880-A Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof 2026-05-26 CN disclosed
CN-122079879-A Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof 2026-05-26 CN disclosed
CN-122079878-A Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof 2026-05-26 CN disclosed
CN-120019043-A Nitrogen-containing heterocyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2025-05-16 CN disclosed
CN-119264042-A Cyclopentane derivative-containing inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2025-01-07 CN disclosed
CN-117105933-A Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity 吉利德科学公司 2023-11-24 CN disclosed
WO-2023139379-A1 MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE (ROCK) REDX PHARMA PLC (GB) 2023-07-27 WO disclosed
WO-2023011446-A1 NOVEL SULFONAMIDE MENIN-MLL INTERACTION INHIBITOR, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 成都苑东生物制药股份有限公司 2023-02-09 WO disclosed
US-20220144850-A1 INDOLO HEPTAMYL OXIME ANALOGUE AS PARP INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-05-12 US disclosed
WO-2008052804-A1 THIAZOLHYDRAZIDES FOR TREATMENT OF NEURODEGENERATIVE DISEASES MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2008-05-08 WO disclosed
EP-1918286-A1 Thiazolhydrazides for treatment of neurodegenerative diseases MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2008-05-07 EP disclosed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed
WO-2007104485-A2 SUBSTITUTED IMIDAZO[2,1-B]THIAZOLE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-09-20 WO disclosed
WO-2007060028-A1 NAPTHYRIDINE COMPOUNDS AS ROCK INHIBITORS GPC BIOTECH AG (DE) 2007-05-31 WO disclosed
EP-1757607-A1 N5-substituted benzo¬2,3|azepino¬4,5-b|indol-6-ones for treating tropical diseases Molisa GmbH (DE) 2007-02-28 EP disclosed
WO-2005023818-A2 HETEROBICYCLIC COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS GPC BIOTECH AG (DE) 2005-03-17 WO disclosed
US-4585472-A PRE- AND POSTEMERGENCE HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1986-04-29 US disclosed
EP-0102542-A2 1,2,4,6-Thiatriazin-1,1-dioxide ethers, process for their preparation and their use as herbicides BASF Aktiengesellschaft (DE) 1984-03-14 EP disclosed